Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05ZEW
|
|||
| Former ID |
DNCL003236
|
|||
| Drug Name |
INO-3510
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Influenza A virus H1N1/H5N1 infection [ICD-11: 1E30] | Phase 1 | [1] | |
| Company |
Inovio Pharmaceuticals
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Human Deoxyribonucleic acid (hDNA) | Target Info | . | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01405885) A Study of DNA Vaccine With Electroporation for the Prevention of Disease Caused by H1 and H5 Influenza Virus. U.S. National Institutes of Health. | |||
| REF 2 | Inovio Receives U.S. Patent for SynCon H1N1 Influenza Universal Vaccine. Inovio. March 26, 2012. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.